Company
ChinaQilu Pharmaceutical Co., Ltd. (Dongjia Site), China – FDA Inspections
Inspection records and compliance data for Qilu Pharmaceutical Co., Ltd. (Dongjia Site). 2 FDA inspections on record, 2 Form 483s, last inspected May 24, 2024.
Company Profile
This profile covers Qilu Pharmaceutical Co., Ltd. (Dongjia Site) based in China.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 2
- Form 483s
- 2
- Warning letters
- 0
First inspected June 16, 2023. Last inspected May 24, 2024.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| May 24, 2024 | Not classified | Human Drugs | 1239802 |
| June 16, 2023 | Not classified | Human Drugs | 1210768 |
FDA documents
Form 483s (2)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Qilu Pharmaceutical Co., Ltd. (Dongjia Site)
FEI Number
3021324493
Address
China
Country
China
ID: cc92034a-0571-4e14-b26d-03e2efd1cd97